Alcamena Stem Cell Therapeutics, LLC
Spencerville, MD Doing business as Alcamena Stem Cell Therapeutics LLC Alcamena Stem Cell Therapeutics
- UEI
- J6DAAQH7AQL8
- CAGE
- 7B1Q9
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 621511 Medical Laboratories Primary
- SAM.gov registration date
- Physical address
- 16311 Batson Rd, Spencerville, MD 20868, USA
- Website
- alcamenabio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A new drug modality to restore cognitive and psychological health after traumatic brain injury | Defense Health Agency | $2,550,000 | |
| FDA phase 1 development of a novel nonopioid cell and tissue permeable peptide therapeutic for epigenetic… | National Institute of Neurological Disorders and Stroke | $3,000,000 | |
| First in class peptidomimetic drug for the treatment of TBI and sequelae nonclinical safety assessment | Defense Health Agency | $1,700,000 | |
| Final-stage preclinical development of a long-acting, non-opioid peptidomimetic drug for chronic pain | Defense Health Agency | $5,599,963 | |
| Optimization and assessment of a biologic to improve functional recovery after peripheral nerve injury | National Institute of Neurological Disorders and Stroke | $699,541 |
About Alcamena Stem Cell Therapeutics, LLC
Alcamena Stem Cell Therapeutics, LLC is a corporate entity registered in SAM.gov since January 2015, operating as a self-certified small disadvantaged business and for-profit limited liability company located in Spencerville, Maryland. The company specializes in developing innovative therapeutic solutions focusing on neurological conditions, pain management, and drug development, with a particular emphasis on peptidomimetic drugs and biologics. Their strategic approach centers on creating novel drug modalities that target complex medical challenges, particularly in areas of neurological health and pain treatment.
The company has secured multiple significant federal grant awards from key agencies like the Defense Health Agency and the National Institute of Neurological Disorders and Stroke, primarily supporting advanced pharmaceutical research and development. Their grant-funded projects include developing a new drug modality to restore cognitive and psychological health after traumatic brain injury, a novel non-opioid cell and tissue-permeable peptide therapeutic for epigenetic reprogramming of neuropathic pain, and preclinical development of long-acting, non-opioid peptidomimetic drugs for chronic pain management. These grants, ranging from $2.55 million for traumatic brain injury research to ongoing projects in pain management, demonstrate Alcamena's commitment to advancing therapeutic solutions that address critical medical needs, with a specific focus on creating innovative treatments that go beyond symptom management to target underlying physiological mechanisms.
Quick answers
What is Alcamena Stem Cell Therapeutics, LLC's UEI?
Alcamena Stem Cell Therapeutics, LLC's Unique Entity ID (UEI) in SAM.gov is J6DAAQH7AQL8.
What is Alcamena Stem Cell Therapeutics, LLC's CAGE code?
Alcamena Stem Cell Therapeutics, LLC's CAGE code is 7B1Q9.
What is Alcamena Stem Cell Therapeutics, LLC's primary NAICS code?
Alcamena Stem Cell Therapeutics, LLC's primary NAICS code is 621511 (Medical Laboratories).
Where is Alcamena Stem Cell Therapeutics, LLC located?
Alcamena Stem Cell Therapeutics, LLC's physical address in SAM.gov is 16311 Batson Rd, Spencerville, MD 20868, USA.
Is Alcamena Stem Cell Therapeutics, LLC registered in SAM.gov?
Yes. Alcamena Stem Cell Therapeutics, LLC's SAM.gov registration is active through August 26, 2027.
What is Alcamena Stem Cell Therapeutics, LLC's most recent federal award?
Alcamena Stem Cell Therapeutics, LLC's most recent federal grant award is A new drug modality to restore cognitive and psychological health after traumatic brain injury (HT94252510912), from Defense Health Agency, on September 1, 2025.
On GovTribe
See Alcamena Stem Cell Therapeutics, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors